(19)
(11) EP 4 771 058 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861193.1

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 16/28; A61K 40/11; A61K 40/31; A61K 40/4202; G01N 2333/705; A61K 40/4211; A61K 2239/49; C12Q 1/6886; C12Q 2600/158; G01N 33/5759
(86) International application number:
PCT/US2024/044799
(87) International publication number:
WO 2025/049995 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363536341 P

(71) Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Bethesda, MD 20817 (US)

(72) Inventor:
  • UPADHYAY, Geeta
    Bethesda, Maryland 20817 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ANTI-LY6 ANTIBODIES AND USES THEREOF